Concord Drugs share news, announcements and annual reports
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹65.99.
30 Oct: open ₹65.99, high ₹65.99, low ₹63.03
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹84 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,732
Concord Drugs share news and announcements
433 announcements, routine notices left out, newest first. Page 9 of 9.
Jul 2016
20 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
19 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
Jun 2016
30 Jun · Board Meeting on July 07, 2016
Meeting of the Board of Directors of the Company will be held on July 07, 2016, inter alia, to consider the following: - Restructuring of the Board.
May 2016
19 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider the following: 1. Audited financial ....
Apr 2016
21 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
20 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
Feb 2016
22 Feb · Limited Review Report for December 31, 2015
Jan 2016
21 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
20 Jan · Authorised KMPs to determine materiality of events/information
Nov 2015
Oct 2015
Sep 2015
1 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2015 to September 30, 2015 (both days inclusive) ....
Aug 2015
Jul 2015
22 Jul · Shareholding Pattern For June 30, 2015
May 2015
18 May · Code of Conduct of Fair Disclosure
14 May · Revised Shareholding Pattern For March 31, 2015
Apr 2015
21 Apr · Shareholding Pattern For March 31, 2015
Mar 2015
31 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 30, 2015, has considered and approved the following : 1. Appointment of ....27 Mar · Board Meeting on March 30, 2015
Meeting of the Board of Directors of the Company will be held on March 30, 2015, inter alia, to consider and approve the following: 1. Appointment ....
Feb 2015
23 Feb · Shareholding Pattern For December 31, 2014
23 Feb · Listing of equity shares of Concord Drugs Ltd
Trading Members of the Exchange are hereby informed that effective from February 23, 2015, the equity shares of Concord Drugs Ltd (Scrip Code: 538965) are listed and admitted to dealings ....